Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 133

Results For "WHO"

2352 News Found

Cellutions BioStorage, a research-to-launch Cryopreservation Bank, inaugurated
Supply Chain | July 16, 2022

Cellutions BioStorage, a research-to-launch Cryopreservation Bank, inaugurated

Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies


India Health Link join hands with Canopi
Supply Chain | July 16, 2022

India Health Link join hands with Canopi

To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India


Enveda appoints Vanitha Sekar as Chief Business Officer
People | July 16, 2022

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences


Cipla Health signs agreement to acquire Endura Mass
News | July 15, 2022

Cipla Health signs agreement to acquire Endura Mass

This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.


CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
News | July 15, 2022

CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine

Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.


Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
Diagnostic Center | July 14, 2022

Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.


USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list
Drug Approval | July 14, 2022

USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list

Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.


SRL Diagnostics launches fatty liver index
Diagnostic Center | July 13, 2022

SRL Diagnostics launches fatty liver index

An algorithm based testing for Fatty Liver Disease


India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData
News | July 11, 2022

India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData

Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small


Feeling younger can help us rehabilitate faster : Study
News | July 11, 2022

Feeling younger can help us rehabilitate faster : Study

Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity